These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35398942)

  • 1. Assessing the dynamic changes in vitiligo: reliability and validity of the Vitiligo Disease Activity Score (VDAS) and Vitiligo Disease Improvement Score (VDIS).
    van Geel N; Depaepe L; Vandaele V; Mertens L; Van Causenbroeck J; De Schepper S; Van Coile L; Van Reempts A; De Vos AS; Papeleu J; Hoorens I; Mertens D; Wolkerstorfer A; Lommerts JE; Speeckaert R
    J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):1334-1341. PubMed ID: 35398942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Severity Strata of Disease Activity and Repigmentation in Vitiligo Based on Validated Physician Global Assessment (PGA) Scores.
    van Geel N; Delbaere L; Mertens L; Vandaele V; Depaepe L; Van Causenbroeck J; De Schepper S; Van Coile L; Van Reempts A; De Vos AS; Papeleu J; Hoorens I; Wolkerstorfer A; Speeckaert R
    J Clin Med; 2024 May; 13(9):. PubMed ID: 38731208
    [No Abstract]   [Full Text] [Related]  

  • 3. Reliability and validity of the Vitiligo Signs of Activity Score (VSAS).
    van Geel N; Passeron T; Wolkerstorfer A; Speeckaert R; Ezzedine K
    Br J Dermatol; 2020 Nov; 183(5):883-890. PubMed ID: 32064583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinician-reported outcome measures for the assessment of vitiligo: A scoping review.
    van Geel N; Duponselle J; Delbaere L; Herbelet S; Eleftheriadou V; Ezzedine K; Forman M; Garg A; Hamzavi IH; Seneschal J; Spuls P; Terwee CB; Wolkerstorfer A; Speeckaert R; Pandya AG
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2231-2242. PubMed ID: 37602494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitiligo Area Scoring Index and Vitiligo European Task Force assessment: reliable and responsive instruments to measure the degree of depigmentation in vitiligo.
    Komen L; da Graça V; Wolkerstorfer A; de Rie MA; Terwee CB; van der Veen JP
    Br J Dermatol; 2015 Feb; 172(2):437-43. PubMed ID: 25278165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The validity, reliability and acceptability of the SAVASI; a new self-assessment score in vitiligo.
    Komen L; van der Kraaij GE; van der Veen JP; de Rie MA; Wolkerstorfer A
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2145-51. PubMed ID: 25868111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a patient-reported outcome measure in vitiligo: The Self Assessment Vitiligo Extent Score (SA-VES).
    van Geel N; Lommerts JE; Bekkenk MW; Prinsen CA; Eleftheriadou V; Taieb A; Picardo M; Ezzedine K; Wolkerstorfer A; Speeckaert R;
    J Am Acad Dermatol; 2017 Mar; 76(3):464-471. PubMed ID: 27887798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability and agreement testing of a new automated measurement method to determine facial vitiligo extent using standardized ultraviolet images and a dedicated algorithm.
    Marin Dit Bertoud Q; Bertold C; Ezzedine K; Pandya AG; Cherel M; Castillo Martinez A; Seguy MA; Abdallah M; Bae JM; Böhm M; Parsad D; Rosmarin D; Wolkerstorfer A; Bahadoran P; Blaise M; Dugourd PM; Philippo V; Delaval JM; Passeron T
    Br J Dermatol; 2023 Dec; 190(1):62-69. PubMed ID: 37615581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of the Vitiligo Area Scoring Index measurement tool for vitiligo.
    Pourang A; Kohli I; Ezekwe N; Parks-Miller A; Mohammad TF; Huggins RH; Lim HW; Deal LS; Lukic T; Zhang F; Hamzavi I
    JAAD Int; 2024 Sep; 16():206-213. PubMed ID: 39040843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures.
    Arkachaisri T; Vilaiyuk S; Li S; O'Neil KM; Pope E; Higgins GC; Punaro M; Rabinovich EC; Rosenkranz M; Kietz DA; Rosen P; Spalding SJ; Hennon TR; Torok KS; Cassidy E; Medsger TA;
    J Rheumatol; 2009 Dec; 36(12):2819-29. PubMed ID: 19833758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability, Validity and Feasibility of the Vitiligo Extent Score (VES) and Self-Assessment Vitiligo Extent Score (SA-VES) Among Vitiligo Patients: A Cross-Cultural Validation.
    Chaweekulrat P; Silpa-Archa N; Apinuntham C; Chaiyabutr C; Wongpraparut C
    Clin Cosmet Investig Dermatol; 2021; 14():949-957. PubMed ID: 34349539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a Patient Global Assessment for extent, severity and impact to define the severity strata for the Self Assessment Vitiligo Extent Score (SA-VES).
    van Geel N; Uitentuis SE; Zuidgeest M; Wolkerstorfer A; Bekkenk MW; Moock C; Van Goethem C; Verlaeckt E; Smet C; Grine L; Speeckaert R
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):216-221. PubMed ID: 32452565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference method for digital surface measurement of target lesions in vitiligo: a comparative analysis.
    van Geel N; Vandendriessche D; Vandersichel E; De Schepper S; Grine L; Mertens L; Vandaele V; Spoelders F; Bekkenk M; Wolkerstorfer A; Prinsen CA; Speeckaert R
    Br J Dermatol; 2019 May; 180(5):1198-1205. PubMed ID: 30207606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of a New Scoring Tool to Evaluate the Clinical Evolution of Adult Patients with Nonsegmental Vitiligo.
    Peralta-Pedrero ML; Herrera-Bringas D; Torres-González KS; Morales-Sánchez MA; Jurado Santa-Cruz F; Cruz-Avelar A
    Dermatology; 2021; 237(6):952-960. PubMed ID: 33486476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of the Vitiligo Extent Score (VES): an International Collaborative Initiative.
    van Geel N; Lommerts J; Bekkenk M; Wolkerstorfer A; Prinsen CAC; Eleftheriadou V; Taïeb A; Picardo M; Ezzedine K; Speeckaert R
    J Invest Dermatol; 2016 May; 136(5):978-984. PubMed ID: 26827762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultraviolet photography in vitiligo: image quality, validity and reliability.
    Uitentuis SE; Heilmann MN; Verdaasdonk RM; Bae JM; Luiten RM; Wolkerstorfer A; Bekkenk MW
    J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):1590-1594. PubMed ID: 31994253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity and Area Score for Hidradenitis (SASH): a novel outcome measurement for hidradenitis suppurativa.
    Kirby JS; Butt M; King T
    Br J Dermatol; 2020 Apr; 182(4):940-948. PubMed ID: 31233623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the Vitiligo Noticeability Scale in clinical trials: construct validity, interpretability, reliability and acceptability.
    Batchelor JM; Gran S; Leighton P; Howells L; Montgomery AA; Tan W; Ahmed I; Thomas KS
    Br J Dermatol; 2022 Oct; 187(4):548-556. PubMed ID: 35596714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Translation and validation of a French version of the Young Mania Rating Scale (YMRS)].
    Favre S; Aubry JM; Gex-Fabry M; Ragama-Pardos E; McQuillan A; Bertschy G
    Encephale; 2003; 29(6):499-505. PubMed ID: 15029084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring disease activity and damage in discoid lupus erythematosus.
    Wahie S; McColl E; Reynolds NJ; Meggitt SJ
    Br J Dermatol; 2010 May; 162(5):1030-7. PubMed ID: 20199547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.